EUVIMEDEUVIMED entdecken
Crossref

Nervous system involvement in primary Sjögren’s syndrome: analysis from the Sjögrenser registry

Ximena Larco-Rojas iD, Mónica Fernandez Castro, Carlos Sánchez-Piedra, Víctor Martínez Taboada, Alejandro Olivé, José Rosas, Raúl Menor, Beatriz Rodríguez, Ángel García-Aparicio, Francisco Javier López Longo, Sara Manrique-Arija iD, Jesús Alberto García Vadillo und 25 weitere

Modern Rheumatology · 04.11.2026 · 36 (6) · 1016-1022

DOI: 10.1093/mr/roag050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 24.06.2026. Verfasst von Ximena Larco-Rojas und 36 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Río Hortega, Rheumatology Department, Valladolid, Spain. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Central Nervous System Diseases. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to describe the clinical characteristics of nervous system involvement in a cohort of patients from the SjögrenSER registry.

Methods

All patients included in the SjögrenSER study, were retrospectively analysed. Patients were classified based on the presence of neurological involvement (central and peripheral nervous systems). We performed descriptive statistical analyses, clinical associations, Student’s t test or χ2 test, and uni- and multivariate logistic regression.

Results

The registry included 437 patients, with peripheral nervous system involvement observed in 39 patients (8.9%) and central nervous system involvement in 34 patients (7.8%). Stroke and ischemic cardiovascular disease were common comorbidities in patients with Sjögren’s disease and neurological involvement (P < .05). Neurological involvement was also associated with other systemic manifestations, including renal involvement (P = .015), glomerulonephritis with cryoglobulinemia (P = .021), and myositis (P = .002). Fatigue was significantly associated with neurological involvement (P = .012). Patients with nervous system involvement more frequently received glucocorticoids, antimalarials, immunosuppressants, intravenous immunoglobulins, and biologic therapies. Steroids and cyclophosphamide were used more often than other medications (OR = 3.33; 1.54–7.18 and OR = 6.80; 1.49–30.96, respectively).

Conclusions

In this cohort, neurological involvement was commonly associated with other systemic manifestations of Sjögren’s disease, such as myositis, suggesting a more severe disease phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeCentral Nervous System DiseasesHumansFemaleRegistriesMiddle AgedMaleAgedRetrospective StudiesAdultComorbidityImmunosuppressive Agents

Stichwörter der Autor:innen

Extraglandular involvementSjögren’s diseasediagnosisneurological involvementphenotypetreatment

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Hospital Universitario Río Hortega, Rheumatology Department, Valladolid, Spain.
  • Hospital Universitario Puerta de Hierro Majadahonda, Rheumatology Department, Madrid, Spain.
  • Unidad de Investigación de la SER, Spain.
  • Instituto de Salud Carlos III, Madrid, Spain.
  • Hospital Universitario Marqués de Valdecilla, Rheumatology Department, Santander, Spain.
  • Facultad de Medicina Universidad de Cantabria, Santander, Spain.

ORCID-Profile: Ximena Larco-Rojas, Sara Manrique-Arija, Sheila Melchor, Javier Loricera

Zitieren

APA

Larco-Rojas, X., Castro, M. F., Sánchez-Piedra, C., Martínez Taboada, V., Olivé, A., Rosas, J., Menor, R., Rodríguez, B., García-Aparicio, Á., López Longo, F. J., Manrique-Arija, S., García Vadillo, J. A., Gil Barato, S., López Gonzalez, R., Narváez, F. J., Galisteo, C., Gonzalez Martín, J., Ruiz Lucea, E., Naranjo, A., …, & Sjögrenser group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER) (2026). Nervous system involvement in primary Sjögren’s syndrome: analysis from the Sjögrenser registry. Modern Rheumatology, 36(6), 1016-1022. https://doi.org/10.1093/mr/roag050

Vancouver

Larco-Rojas X, Castro MF, Sánchez-Piedra C, Martínez Taboada V, Olivé A, Rosas J, et al. Nervous system involvement in primary Sjögren’s syndrome: analysis from the Sjögrenser registry. Modern Rheumatology. 2026;36(6):1016-1022. doi:10.1093/mr/roag050

BibTeX
@article{LarcoRojas2026,
  author = {Larco-Rojas, Ximena and Castro, Mónica Fernandez and Sánchez-Piedra, Carlos and Martínez Taboada, Víctor and Olivé, Alejandro and Rosas, José and Menor, Raúl and Rodríguez, Beatriz and García-Aparicio, Ángel and López Longo, Francisco Javier and Manrique-Arija, Sara and García Vadillo, Jesús Alberto and Gil Barato, Susana and López Gonzalez, Ruth and Narváez, Francisco Javier and Galisteo, Carlos and Gonzalez Martín, Jorge and Ruiz Lucea, Esther and Naranjo, Antonio and Illera, Óscar and Melchor, Sheila and Moreira, Begoña and Raya, Enrique and Puga Guzmán, José Luis and Cid, Natalia and Júdez, Enrique and Moriano, Clara and Torrente-Segarra, Vicente and Corominas, Héctor and García Magallón, Blanca and Guillén Astete, Carlos and Castellvi, Ivan and Bohórquez, Cristina and Loricera, Javier and Alcorta Lorenzo, Nerea and Andreu, Jose Luis and Sjögrenser group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER), Sjögrenser group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER)},
  title = {Nervous system involvement in primary Sjögren’s syndrome: analysis from the Sjögrenser registry},
  journal = {Modern Rheumatology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {1016--1022},
  doi = {10.1093/mr/roag050}
}
Kostenlos starten →